Anzeige
Mehr »
Login
Samstag, 08.02.2025 Börsentäglich über 12.000 News von 685 internationalen Medien
Die Zukunft ist jetzt: Wie die Robotik-Revolution den US-Aktienmarkt in den Schatten stellt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2JPMY | ISIN: US64131A1051 | Ticker-Symbol: NRC
Tradegate
07.02.25
19:26 Uhr
2,995 Euro
+0,005
+0,17 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
NEURONETICS INC Chart 1 Jahr
5-Tage-Chart
NEURONETICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
2,9403,04007.02.
2,9753,00007.02.

Aktuelle News zur NEURONETICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrNeuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)7
FrNeuronetics prices $18M offering2
FrNeuronetics shares drop as it prices $18M public offering of common stock2
FrNeuronetics Announces Pricing of $18 Million Underwritten Public Offering of Common Stock3
DoNeuronetics announces public stock offering3
DoNeuronetics shares fall on launch of public offering of common stock9
DoNeuronetics Announces Launch of Underwritten Public Offering of Common Stock10
DiNeuronetics, Inc. - S-8, Securities to be offered to employees in employee benefit plans1
NEURONETICS Aktie jetzt für 0€ handeln
DiWhy Neuronetics Inc (STIM) Is Skyrocketing So Far In 20253
29.01.Neuronetics: NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression13
13.01.Neuronetics prognostiziert Umsatzwachstum und Kosteneinsparungen nach Übernahme19
13.01.Neuronetics Provides Business Update and Issues 2025 Guidance59Preliminary unaudited fourth quarter and full year revenue 2024 was $22.1 and $74.5, respectivelyClosed acquisition of Greenbrook TMS effective as of December 9, 2024Expects full year 2025 pro forma...
► Artikel lesen
13.01.Neuronetics, Inc. - 8-K, Current Report1
16.12.24Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)151MALVERN, Pa., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the "Company") today announced the granting of inducement awards to new employees as described below. In accordance...
► Artikel lesen
10.12.24Neuronetics, Inc. - 8-K, Current Report-
10.12.24Neuronetics and Greenbrook TMS Announce Closing of Transaction51MALVERN, Pa. and TORONTO, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) ("Neuronetics") and Greenbrook TMS Inc. (OTCMKTS: GBNHF) ("Greenbrook", and together with Neuronetics,...
► Artikel lesen
15.11.24Greenbrook TMS Inc.: Greenbrook Receives Final Court Approval For Arrangement With Neuronetics20TORONTO, Nov. 15, 2024 /CNW/ - Greenbrook TMS Inc. (OTC: GBNHF) ("Greenbrook" or the "Company") is pleased to announce that the Company has obtained a final order...
► Artikel lesen
13.11.24Neuronetics, Inc. - 8-K, Current Report-
12.11.24Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)74MALVERN, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
► Artikel lesen
12.11.24Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results173MALVERN, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the "Company" or "Neuronetics") a commercial stage medical technology company with a strategic vision of transforming...
► Artikel lesen
Seite:  Weiter >>
56 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1